ArticleScientific reports2022

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.

Tadamichi Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.